|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hung yp"
Showing items 6-15 of 49 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2022-11 |
BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma
|
Chiang, NJ;Hung, YP;Lien, MY;Wu, SY;Chang, WL;Bai, LY;Hsiao, CF;Chen, SH;Wu, IC;Chen, MH |
| 國家衛生研究院 |
2022-07-18 |
Impaired chromatin remodeling predicts survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract cancer: A phase II T1219 study
|
Chiang, NJ;Tan, KT;Bai, LY;Hsiao, CF;Huang, CY;Hung, YP;Huang, CJ;Chen, SC;Shan, YS;Chao, Y;Huang, YH;Lee, IC;Lee, PC;Su, YY;Chen, SJ;Yeh, CN;Chen, LT;Chen, MH |
| 國家衛生研究院 |
2021-06-21 |
Risk of non-typhoidal Salmonella vascular infections is increased with degree of atherosclerosis and inflammation: A multicenter study in southern Taiwan
|
Chen, YW;Tang, HJ;Tsai, YS;Lee, NY;Hung, YP;Huang, CF;Lee, CC;Li, CW;Li, MC;Syue, LS;Su, SL;Hsu, SH;Ko, WC;Chen, PL |
| 中山醫學大學 |
2021 |
Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan
|
Hung, YP; Tsai, CS; Tsai, BY; Tsai, PJ; Lee, YT; Lee, JC; Liu, HC; Hsueh, PR; Lee, CC; Ko, WC |
| 國家衛生研究院 |
2020-12-02 |
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
|
Chen, CP;Lin, YC;Chen, TC;Tseng, TY;Wong, HL;Kuo, CY;Lin, WP;Huang, SR;Wang, WY;Liao, JH;Liao, CS;Hung, YP;Lin, TH;Chang, TY;Hsiao, CF;Huang, YW;Chung, WS;Cheng, CY;Cheng, SH |
| 國家衛生研究院 |
2020-09-17 |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen, SY;Lee, YL;Lin, YC;Lee, NY;Liao, CH;Hung, YP;Lu, MC;Wu, JL;Tseng, WP;Lin, CH;Chung, MY;Kang, CM;Lee, YF;Lee, TF;Cheng, CY;Chend, CP;Huang, CH;Liu, CE;Cheng, SH;Ko, WC;Hsueh, PR;Chen, SC |
| 國家衛生研究院 |
2020-06-30 |
Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response
|
Pan, YR;Wu, CE;Wang, YC;Yeh, YC;Lu, ML;Hung, YP;Chao, Y;Yeh, DW;Lin, CH;Hsieh, JCH;Chen, MH;Yeh, CN |
| 國家衛生研究院 |
2020-01 |
Proton-pump inhibitor exposure aggravates clostridium difficile-associated colitis: Evidence from a mouse model[Erratum:Journal of Infectious Diseases. 2015 Aug 15;212(4):654-663.]
|
Hung, YP;Ko, WC;Chou, PH;Chen, YH;Lin, HJ;Liu, YH;Tsai, HW;Lee, C;Tsai, PJ |
| 中山醫學大學 |
2020 |
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
|
Chen, CP; Lin, YC; Chen, TC; Tseng, TY; Wong, HL; Kuo, CY; Lin, WP; Huang, SR; Wang, WY; Liao, JH; Liao, CS; Hung, YP; Lin, TH; Chang, TY; Hsiao, CF; Huang, YW; Chung, WS; Cheng, CY; Cheng, SH |
| 國家衛生研究院 |
2019-12-18 |
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas
|
Chen, MH;Chou, WC;Hsiao, CF;Jiang, SS;Tsai, HJ;Liu, YC;Hsu, C;Shan, YS;Hung, YP;Hsich, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
Showing items 6-15 of 49 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
|
